TXNIP and Hyperglycemia: Similarly, hyperglycemia-induced TXNIP can activate p38 and Erk1/2 MAPK pathways in pancreatic cancer model and TXNIP expression is positively correlated with poor prognosis in pancreatic cancer patients [17].